Lotus Eye Hospital and Institute Ltd
LOTUSEYELotus Eye Hospital and Institute Ltd
LOTUSEYE
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 101.82 | 2.37 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.23 | 6.64 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.
Peers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31.71 | 34.67 | 38.93 | 39.11 | 41.48 | 33.20 | 39.80 | 48.19 | 49.52 | 50.04 | ||||||||||
Raw Materials | 8.40 | 10.27 | 10.89 | 6.18 | 6.11 | 4.76 | 5.69 | 6.93 | 7.05 | 43.59 | ||||||||||
| Power & Fuel Cost | 0.96 | 0.98 | 1.11 | 1.24 | 1.22 | 0.96 | 0.85 | 1.03 | 1.38 | |||||||||||
| Employee Cost | 5.80 | 7.00 | 7.78 | 8.49 | 8.17 | 6.82 | 6.98 | 8.52 | 9.25 | |||||||||||
| Selling & Administrative Expenses | 5.12 | 5.52 | 6.33 | 6.38 | 6.51 | 4.06 | 5.18 | 5.96 | 6.17 | |||||||||||
| Operating & Other expenses | 6.86 | 6.89 | 7.56 | 12.92 | 15.29 | 12.14 | 14.29 | 16.91 | 17.73 | |||||||||||
EBITDA | 4.57 | 4.01 | 5.26 | 3.90 | 4.18 | 4.46 | 6.81 | 8.84 | 7.94 | 6.45 | ||||||||||
| Depreciation/Amortization | 4.44 | 3.44 | 3.37 | 3.06 | 2.50 | 2.33 | 2.50 | 2.98 | 3.73 | 4.39 | ||||||||||
| PBIT | 0.13 | 0.57 | 1.89 | 0.84 | 1.68 | 2.13 | 4.31 | 5.86 | 4.21 | 2.06 | ||||||||||
| Interest & Other Items | 0.16 | 0.15 | 0.18 | 0.21 | 0.24 | 0.14 | 0.21 | 0.20 | 0.20 | 0.21 | ||||||||||
| PBT | -0.03 | 0.42 | 1.71 | 0.63 | 1.44 | 1.99 | 4.10 | 5.66 | 4.01 | 1.85 | ||||||||||
| Taxes & Other Items | -0.12 | -0.03 | -0.04 | -0.08 | 0.39 | 0.42 | 1.11 | 1.57 | 1.10 | 0.47 | ||||||||||
| Net Income | 0.09 | 0.45 | 1.75 | 0.71 | 1.05 | 1.57 | 2.99 | 4.09 | 2.91 | 1.38 | ||||||||||
| EPS | 0.04 | 0.22 | 0.84 | 0.34 | 0.50 | 0.75 | 1.44 | 1.97 | 1.40 | 0.66 | ||||||||||
| DPS | 0.00 | 0.50 | 0.50 | 0.00 | 0.00 | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 2.31 | 0.59 | 0.00 | 0.00 | 0.66 | 0.35 | 0.25 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Lotus Eye Hospital and Institute Ltd | 48.28 | 2.37 | — |
| Max Healthcare Institute Ltd | 104.80 | 13.18 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 115.96 | 14.23 | 0.22% |
| Fortis Healthcare Ltd | 86.16 | 6.03 | 0.15% |
Price Comparison
Compare LOTUSEYE with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 1.36%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 14, 2018
Dividend/Share
₹0.50
Ex DateEx Date
Sep 14, 2018
Cash Dividend
Ex DateEx DateAug 2, 2017
Dividend/Share
₹0.50
Ex DateEx Date
Aug 2, 2017
Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended September 2024 as against Rs 0.85 crore during the previous quarter ended September 2023. Sales rose 1.41% to Rs 12.91 crore in the quarter ended September 2024 as against Rs 12.73 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.9112.73 1 OPM %8.9114.22 - PBDT1.342.07 -35 PBT0.111.18 -91 NP0.100.85 -88 Powered by Capital Market - Live
Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended June 2024 as against Rs 1.38 crore during the previous quarter ended June 2023. Sales rose 2.55% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 12.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8912.57 3 OPM %12.9618.93 - PBDT1.922.64 -27 PBT0.861.91 -55 NP0.621.38 -55 Powered by Capital Market - Live
Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the company will be held on 13 August 2024.Powered by Capital Market - Live
BRIEF-Lotus Eye Hospital And Institute - Names Kavetha Sundaramoorthy As Chairman - Investing.com India
BRIEF-Lotus Eye Hospital And Institute Ltd - Approved Appointment Of K.S. Ramalingam As CEO - Investing.com India
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 4.83%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.11% to 0.08%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 32.59%, vs industry avg of 42.9%